Navigation Links
Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
Date:12/8/2012

develop heart failure earlier than the general population, and the overall survival rate following diagnosis is less than 50 percent.

By analyzing transplant patient demographics such as age and gender, treatment strategy (i.e., pre-HCT chemotherapy and chest radiation), and presence of cardiovascular risk factors such as high blood pressure, diabetes, and high cholesterol, researchers have been able to create a clinical profile to determine which patients are likely to develop heart failure after transplant. However, this current profile is limiting, as it fails to accurately explain the wide variability in the risk of heart failure between individual patients. Importantly, it does not account for how individuals' genetic makeup can exacerbate their risk of developing heart failure.

Seeking additional insight into how genetics can influence the risk for developing heart failure later in life, researchers conducted a case-control study to identify the genetic pathways that may make certain transplant survivors more sensitive to the toxicities of pre-transplant chemotherapy and subsequently increase their risk of heart failure. In this study, the investigators evaluated specific genes responsible for the breakdown of anthracyclines into toxic byproducts (CBR1, CBR3, NQO1, MRP1, and MRP2), defense from oxidative stress, a condition that causes damage to healthy heart cells (NCF4, RAC2, CYBA, SOD), iron overload (HFE), and blood pressure and heart rate regulation (AGT, AGTR1, ACE and ADRB1, ADRB2) in 77 patients with leukemia, lymphoma, and myeloma who underwent a transplant at City of Hope between 1988 and 2007 and later developed congestive heart failure. Investigators matched the survivors with 178 controls (transplant survivors who did not experience heart failure).

After comparing the genetic makeup of the transplant survivors who developed heart failure to their controls, researchers found that patients who had variations in the MRP2,
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
2. Benefit6 Whole Body Protection, a New Product by I Do Strive LLC, Provides Increased Energy Production According to Recent Studies
3. Sharp spike in computer-related injuries predicted for medical workers, find studies
4. Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
5. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
6. New studies show effects of mammography guideline changes
7. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
8. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
9. Cancer Drug Reduced Relapses in MS Patients: Studies
10. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
11. Studies Show Limits, Promise of Laser Removal of Tattoos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014 Air Conditioning & Heating Inc. ... authorized Daikin comfort pro dealer. This means that the ... and cooling system equipment. Only a select few businesses ... before being approved. , Daikin co-developed an R-410A refrigerant ... System Air Conditioning Market. They are also the inventor ...
(Date:7/22/2014)... July 22, 2014 Dr. Dental is excited ... patients and new visitors in mind, one of the main ... visual layout that makes navigation very easy. Dr. Dental is ... of going to the dentist affordable, convenient and fun, and ... new feature is an appointment scheduling system right on the ...
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 Dr. ... with his surgical colleagues, have recently discussed the reasons ... Many leaders in the periodontics profession are seeing the ... go up exponentially. In fact, one surgeon reported that ... failing implants. Although dental implants have a very high ...
(Date:7/22/2014)... The 2014 Warrior-Family Symposium (WFS) ... Building and International Trade Center in Washington, D.C. ... Civilian Communities,” will be held from 8:30 a.m. ... and cohosted by the Military Officers Association of ... (NDIA). USAA is the Executive Sponsor of the ...
(Date:7/22/2014)... United Benefit Advisors (UBA), the nation's leading ... an insurance veteran with more than 15 years of ... based in the company's Chicago office. , UBA Board ... chose to accept this important, strategic position with UBA. ... challenges facing UBA and its Partners as we move ...
Breaking Medicine News(10 mins):Health News:Air Conditioning & Heating Inc. Now an Authorized Daikin Comfort Pro Dealer 2Health News:Dr. Dental Reveals Exciting New Website 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 3Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 2Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 4Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 5
... as soon as possible, researchers say , MONDAY, May ... breast lesions found in women with a high risk ... suggest. , An indeterminate breast lesion is one that ... women include those who have breast cancer, a history ...
... urged to consider risks of hormone treatment, inform patients ... widely used class of prostate cancer drugs called gonadotropin-releasing ... attack, stroke and sudden death in men, a U.S. ... on initial findings from a preliminary and ongoing analysis ...
... While timely care can reduce stress among breast cancer ... compromise other factors important to care, such as safety, effectiveness, ... the April issue of the Journal of the American ... cancer diagnosis and one in eight women will receive ...
... States will have an osteoporosis-related fracture in her lifetime (1). ... 2010 issue of the Journal of the American Academy ... women will be tested and treated for osteoporosis, which if ... fractures. "Less than 10 percent of patients who sustain ...
... ... Medical Group, a Torrance, California-based healthcare organization, today announced the acquisition of Talbert ... managed care patients in Los Angeles County and Orange County, California. , ... Torrance, CA ...
... key, study finds , MONDAY, May 3 (HealthDay News) ... their children from becoming bullies by helping them with ... study suggests. , "Improving parent-child communication and parental ... on child bullying," said study author Dr. Rashmi Shetgiri, ...
Cached Medicine News:Health News:Aggressive Action Urged When Evaluating Breast Lesions 2Health News:FDA Reviews Side Effects From Prostate Cancer Therapy 2Health News:Study evaluates importance of timeliness of care in breast cancer diagnosis and treatment 2Health News:Study evaluates importance of timeliness of care in breast cancer diagnosis and treatment 3Health News:Women want answers, but what questions should be asked? 2Health News:Women want answers, but what questions should be asked? 3Health News:HealthCare Partners Medical Group Expands to Orange County. HealthCare Partners and Talbert Medical Group Join Forces 2Health News:HealthCare Partners Medical Group Expands to Orange County. HealthCare Partners and Talbert Medical Group Join Forces 3Health News:Involved Parents Less Likely to Raise Bullies 2
(Date:7/22/2014)... -- Edwards Lifesciences Corporation (NYSE: EW ), the ... hemodynamic monitoring, announced that Edwards, Chairman and CEO ... panelist at the invitation of the United States Energy ... device innovation at its hearing, "21 st Century ... "Edwards has five decades of experience in ...
(Date:7/22/2014)... -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that ... the market closes on Tuesday, August 5, 2014.  A ... on Tuesday, August 5, 2014, at 4:30 p.m. Eastern ... in the call, please dial 877-303-1298 (for U.S. callers) ... teleconference will be available for one week and can ...
(Date:7/22/2014)...  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... quarter financial results on Tuesday, August 5, 2014, after ... host a live audio webcast immediately following the announcement ... business and financial update and discuss second quarter 2014 ... live audio webcast via the Investors & Media section ...
Breaking Medicine Technology:Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2
... , ENGLEWOOD, Colo., Dec. 7 Baxa Corporation is ... week,s ASHP Midyear Clinical Meeting (MCM). DoseEdge is a ... efficiency through the management of IV and oral dose ... practice and techniques, while providing a framework for reducing ...
... Dec. 7 Genoptix, Inc. (Nasdaq: GXDX ), a ... the Deutsche Bank 2009 MedTools Investor Conference to be held ... 2009. , Genoptix,s EVP and COO, Sam Riccitelli, ... December 9, 2009. He will provide an overview of ...
Cached Medicine Technology:Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... kit measures the biologically active form ... is a valuable prognostic marker for cardiovascular ... plasma vitamin B6 level and Coronary Heart ... reactions of homocysteine to cystathionine and then ...
... volume for use with 4, 8, or 12 ... withdrawal of nearly all of the solution. Corners ... Made of natural virgin polystyrene containing no regrinds. ... by irradiation. Dimensions: 78 mm W x 152 ...
Volume: 10 ml; Volume Graduation: 1/10 ml...
Medicine Products: